Abeona Therapeutics Inc. (ABEO)

NASDAQ: ABEO · IEX Real-Time Price · USD

4.120

-0.080 (-1.90%)

At close: Jul 2, 2024, 4:00 PM

4.200

+0.080 (1.94%)

After-hours: Jul 2, 2024, 6:00 PM EDT

Abeona Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1998
Revenue	3.5	1.41	3	10	0	Upgrade
Revenue Growth (YoY)	147.52%	-52.87%	-70.00%	-	-	Upgrade
Gross Profit	3.5	1.41	3	10	0	Upgrade
Selling, General & Admin	19	17.26	21.64	23.78	20.71	Upgrade
Research & Development	31.09	28.97	38.73	30.14	48.57	Upgrade
Other Operating Expenses	-1.07	5.66	32.47	37.5	7.82	Upgrade
Operating Expenses	49.03	51.88	92.84	91.42	77.09	Upgrade
Operating Income	-45.53	-50.47	-89.84	-81.42	-77.09	Upgrade
Interest Expense / Income	0.42	0.74	3.66	4.12	0.4	Upgrade
Other Expense / Income	8.24	-11.51	-8.56	-1.3	-1.21	Upgrade
Pretax Income	-54.19	-39.7	-84.94	-84.23	-76.28	Upgrade
Net Income	-54.19	-39.7	-84.94	-84.23	-76.28	Upgrade
Preferred Dividends	0	3.78	0	0	0	Upgrade
Net Income Common	-54.19	-43.48	-84.94	-84.23	-76.28	Upgrade
Shares Outstanding (Basic)	21	8	4	4	2	Upgrade
Shares Outstanding (Diluted)	21	8	4	4	2	Upgrade
Shares Change	171.96%	99.65%	6.24%	84.02%	5.95%	Upgrade
EPS (Basic)	-2.53	-5.53	-21.57	-22.75	-37.75	Upgrade
EPS (Diluted)	-2.53	-5.53	-21.57	-22.75	-37.75	Upgrade
Free Cash Flow	-37.14	-41.88	-69.82	-36.36	-69.13	Upgrade
Free Cash Flow Per Share	-1.74	-5.33	-17.73	-9.81	-34.32	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	-	Upgrade
Operating Margin	-1300.86%	-3568.95%	-2994.53%	-814.20%	-	Upgrade
Profit Margin	-1548.23%	-3074.82%	-2831.20%	-842.34%	-	Upgrade
Free Cash Flow Margin	-1061.03%	-2961.74%	-2327.20%	-363.55%	-	Upgrade
EBITDA	-50.57	-34.38	-76.82	-74.52	-67.21	Upgrade
EBITDA Margin	-1444.91%	-2431.61%	-2560.53%	-745.18%	-	Upgrade
Depreciation & Amortization	3.2	4.58	4.46	5.6	8.68	Upgrade
EBIT	-53.77	-38.96	-81.28	-80.12	-75.88	Upgrade
EBIT Margin	-1536.29%	-2755.30%	-2709.33%	-801.19%	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).